New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
ChromaDex Corporation
CDXC
Shape
US Flag

NASDAQ

EPS improving

EPS improving

590M

Biotechnology

7.72USD
Shape0.08 ( 1.05%)
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

-59%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

3%

Quote Panel

Shape
Updated December 1, 2024
1W 3.49 % 1M 34.49 % 3M 135.37 % 1Y 451.43 %

Key Metrics

Shape
  • Market Cap

    589.68M


  • Shares Outstanding

    76.38M


  • Share in Float

    48.21M


  • Dividende

    0


  • Earning Date

    No Data


  • Price Target

    7.72


  • Average Volume

    1.17M


  • Beta

    1.88


  • Range

    1.32-7.9738


  • Industry

    Biotechnology


  • Website

    https://www.chromadex.com


  • Sector

    Healthcare


Fundamentals

Shape

681.98x

P/E Ratio

5.84x

P/S Ratio

17.06x

P/B Ratio

0.0

Debt/Equity

1.5%

Net Margin

$0.0

EPS

How CDXC compares to sector?

P/E Ratio

Relative Strength

Shape

CDXC

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$118M

Shape239%

2025-Revenue

$0.13

Shape436%

2025-EPS

$38M

Shape-2035%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

N/A

-0.02
vs -0.08

Q1.23

arrow
arrow

N/A

-0.03
vs -0.11

Q2.23

arrow
arrow

N/A

-0.03
vs -0.09

Q3.23

arrow
arrow

N/A

-0.01
vs -0.04

Q4.23

arrow
arrow

+108%

0
vs -0.02

Q1.24

arrow
arrow

N/A

-0.01
vs -0.03

Q2.24

arrow
arrow

N/A

-0.00
vs -0.03

Q3.24

arrow
arrow

+300%

0.02
vs -0.01

Q4.24

arrow
arrow

+1380%

0.02
vs 0

Q1.25

arrow
arrow

+298%

0.02
vs -0.01

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

+18%

21M  vs 17.8M

Q1.23

arrow
arrow

+31%

22.6M  vs 17.3M

Q2.23

arrow
arrow

+21%

20.3M  vs 16.7M

Q3.23

arrow
arrow

+14%

19.5M  vs 17.1M

Q4.23

arrow
arrow

+1%

21.2M  vs 21M

Q1.24

arrow
arrow

-2%

22.2M  vs 22.6M

Q2.24

arrow
arrow

+12%

22.7M  vs 20.3M

Q3.24

arrow
arrow

+79%

34.9M  vs 19.5M

Q4.24

arrow
arrow

+26%

26.8M  vs 21.2M

Q1.25

arrow
arrow

+25%

27.7M  vs 22.2M

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

+2%

0.02
vs 0.05

Q1.23

arrow
arrow

-5%

-0.05
vs 0.02

Q2.23

arrow
arrow

-8%

-0.08
vs -0.05

Q3.23

arrow
arrow

-4%

-0.04
vs -0.08

Q4.23

arrow
arrow

+0%

0
vs -0.04

Q1.24

arrow
arrow

-2%

-0.02
vs 0

Q2.24

arrow
arrow

0%

-0.00
vs -0.02

Q3.24

arrow
arrow

+5%

0.05
vs -0.00

Institutionnal OwnershipShape

status-upQoQ

Q4.22

arrow
arrow

58

58
vs 59

-2%

Q1.23

arrow
arrow

60

60
vs 58

3%

Q2.23

arrow
arrow

57

57
vs 60

-5%

Q3.23

arrow
arrow

55

55
vs 57

-4%

Q4.23

arrow
arrow

53

53
vs 55

-4%

Q1.24

arrow
arrow

70

70
vs 53

32%

Q2.24

arrow
arrow

81

81
vs 70

16%

Q3.24

arrow
arrow

93

93
vs 81

15%

Earnings Growth

Latest News